Somatic hypermutation of immunoglobulin variable region (IgV) genes and affinity maturation of the antibody response are the hallmarks of the germinal center (GC) reaction in T celldependent immune responses. Determining the consequences of the experimental manipulation of the GC response on somatic hypermutation and affinity maturation requires the availability of a system that allows measuring these parameters. Immunization of mice of the C57/Bl6 genetic background with the hapten 4-hydroxy-3-nitrophenyl-acetyl (NP) coupled to a carrier protein leads to the predominant usage of one particular IgV heavy chain gene segment, V186.2, among the responding B cells. Moreover, a specific somatic mutation in codon 33 of V186.2 that leads to a tryptophan to leucine amino-acid exchange increases the affinity of the corresponding antibody by ~10-fold, thus representing a molecular marker for affinity maturation. In addition, due to the simplicity of the antigen and the virtual absence of NP-specific plasma cells prior to immunization, NP-based immunizations represent ideal tools to quantify the plasma cell response by measuring NP-specific antisera by ELISA and the generation of NP-specific plasma cells by ELISPOT analysis. We here describe approaches to i) measure the anti-NP plasma cell response by ELISA and ELISPOT analysis, and to ii) amplify and sequence V186.2 rearrangements from GC B cells and plasma cells to determine the level of somatic hypermutation and the extent of affinity maturation in the anti-NP response.
Introduction
Antigen-specific memory B cells and plasma cells are generated during the germinal center (GC) reaction of T cell-dependent immune responses in secondary lymphoid tissues (1, 2). Within the GC microenvironment, antigen-activated B cells undergo somatic hypermutation of the rearranged IgV genes with the aim to generate high-affinity antibodies that effectively bind to the invading pathogen, resulting in its elimination. In a defined area within the GC called dark zone, the rapidly proliferating 'dark zone' cells hypermutate their IgV genes and then differentiate into 'light zone' cells that are positively selected for improved antigen-binding in the GC light zone (2) (3) (4) (5) . Selected light zone B cells recirculate to the dark zone to undergo additional rounds of mutation and selection to further improve antigen-affinity before they eventually differentiate into memory B cells or plasma cells that exit the GC. The descendants of the GC reaction thus carry somatically mutated IgV genes and have often switched from IgM to other Ig classes which have different effector functions.
Understanding the molecular mechanism of the GC response is critical for the development of improved vaccines against microorganisms. Thus, for studies aimed at manipulating the GC response, which e.g. may include the deletion or overexpression of GCassociated genes or the use of particular adjuvants, it is imperative to have tools that allow the investigation of the processes that underlie the generation of antigen-specific memory B cells and plasma cells, i.e. somatic hypermutation and antibody affinity maturation. In C57/Bl6 mice, the immune response against the hapten 4-hydroxy-3-nitrophenyl-acetyl (NP) coupled to a carrier protein frequently results in a specific, affinity-enhancing hypermutation in codon 33 of the V186.2 gene segment that leads to an amino acid exchange resulting in a ~10-fold increase in affinity against NP (6) (7) (8) , allowing for the generation of NP-specific GC B cells, memory B cells and plasma cells to be tracked at the molecular level. The resulting antibodies are mostly of the IgG1 class (6) (7) (8) . The characterization of the B-cell response against NP at the molecular level by several groups (9) (10) (11) provided the baseline for numerous studies on the extent of affinity maturation in situations where certain genes were either knocked out in the mouse germ-line or conditionally deleted in GC B cells (12) (13) (14) (15) (16) .
By immunizing mice with NP coupled to a carrier protein such as chicken gammaglobulin (CGG) or keyhole limpet hemocyanin (KLH), the characteristics and dynamics of the immune response against the hapten in the presence or absence of a certain signaling pathway or transcription factor, or a specific treatment, can be investigated by i) determining the somatic hypermutation frequency in V186.2 gene rearrangements, ii) the fraction of B cells with the affinity-enhancing tryptophan to leucine amino-acid exchange, iii) the quantity of NPspecific serum IgG1 secreted by GC-derived plasma cells by ELISA, and iv) the frequency of plasma cells in lymphoid tissues by ELISPOT analysis. The use of the NP system is not confined to T cell-dependent antibody responses, as the coupling of NP to lipopolysaccharide (LPS) or the polysaccharide Ficoll allows the study of the plasma cell response in T cell-independent responses type I and II, respectively, by ELISA.
Materials

Immunization
 Sterile phosphate-buffered saline (PBS).
 NP-KLH (e.g. NP28-KLH, Biosearch Technologies; of note, the number of NP molecules conjugated to KLH varies among batches).  Vortex.
 Sonicator.
Acquisition of blood samples and serum preparation
 Razor blade or scalpel.
 1 ml or 2 ml syringes.
 21G1 needles.
 1.5 ml collection tubes.
 Centrifuge.
ELISA
 96-well immune plates (Thermo Fisher Scientific).
 96-well culture plates.
 Parafilm.
 PBS.
 2% fetal bovine serum (FBS) in PBS.
 Wash buffer: PBS containing 0.05% Tween-20.
 Capture antibody: anti-mouse Ig(H+L) (Southern Biotec).
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 NP-bovine serum albumin (BSA) with low and high hapten coating (e.g. NP9-BSA and NP25-BSA).
 Mouse Ig (e.g. IgM, IgG1).
 Detection antibody: alkaline phosphatase (AP)-conjugated anti-mouse Ig (e.g. IgM, IgG1).
 PNPP (p-nitrophenylphosphate; Southern Biotec).
 Substrate buffer (500 ml): ddH2O + 24.5 mg MgCl2x6H2O + 48 ml diethanolamine; adjust pH to 9.8 with 5N HCl.
 Microplate reader.
Sample generation from mouse tissues following NP immunization
 PBS/0.5% BSA  Glass slides; alternatively 40 µm cell strainer, 50 ml falcon tube and plunger of a 5 ml syringe.
 10 ml syringes.
 22G1 needles.  Refrigerated centrifuge.
 Optional: cell counter (e.g. Countess, Invitrogen).
ELISPOT
 96-well filtration plates (Millipore, Cat# MSIPS4510).
 Plastic wrap.
 0.2 µm filter.
 35% ethanol (diluted in molecular grade H2O).
 Sterile PBS.
 RPMI culture medium supplemented with 10% fetal bovine serum (FBS), 1%
Penicillin/Streptomycin and 0.1% -mercaptoethanol.
 PBS/2% BSA.
 NP-BSA with high hapten coating (e.g. NP25-BSA).
 Detection antibody: AP-conjugated anti-mouse IgG1.
 Nitro blue tetrazolium chloride-5-bromo-4-chloro-3-indolyl phosphate (NBT/BCIP; Roche).
 NBT/BCIP substrate buffer: 0.1 M Tris + 0.1 M NaCl + 0.05 M MgCl2; pH 9.5.
 Optional: cell counter.
 Microplate reader (alternatively, colonies can be counted using a magnifying glass and pictures of wells can be taken with a camera that has a macro function).
Isolation of B-cell subsets from immunized mice by FACS
 RBC lysis buffer (see above).
 PBS/0.5% BSA.
 Glass slides; alternatively 40 µm cell strainer, 50 ml falcon tube and plunger of a 5 ml syringe.
 15 ml Falcon tubes.
 MidiMACS Separator (Miltenyi Biotech).
 MidiMACS Separation Units (columns) (Miltenyi Biotech).
 'Untouched' B-cell isolation kit (Miltenyi Biotech).  26G½ needles and 1 ml syringes.
 Glycogen.
 DEPC-treated water.
 UV spectrometer (e.g., NanoDrop ND-8000 Spectrophotometer; NanoDrop Technologies).
 cDNA synthesis kit (e.g. from Invitrogen or an equivalent kit).
 PCR thermocycler.
 PCR tubes.
 dNTPs.
 Gene-specific primers (Table 1) .
 Taq polymerase and reagents for PCR amplification.
 Gel electrophoresis unit with appropriate buffer.
 Agarose and agarose plates.
 Ethidium bromide.
 Gel imaging system.
 TA-cloning vector; pGEM-TEasy (Promega).
 Competent bacteria (DH5).
 SOC medium.
 Ampicillin.
Methods
Primary and secondary immunization with NP
The general approach is summarized in Fig. 1 knockout genotype the NP9/NP25 ratio was lower compared to the proficient controls, this would indicate that affinity maturation in this genotype is impaired.
13. For T-independent immunization, see Notes 1.
Detection of antibody secretion by ELISPOT
All steps on day 1 and day 2 have to be performed under the hood to keep the plates sterile. Do every condition in duplicate. The general approach is summarized in Fig. 1 .
Preparation of the plates (day 1)
1. Pre-wet each well of a filtration plate with 15 l of 35% ethanol for a maximum of 1 min.
2. Wash each well of the plate 3x with 200 l sterile PBS.
3. Coat each well with 100 l of 5 mg/ml NP-BSA (e.g. NP25-BSA) diluted in PBS.
Wrap the plate tightly in plastic wrap and incubate at 4°C o/n.
Sample preparation (day 2)
4. At least 2 hours before addition of the samples, discard the coating solution and wash the plate 3x with sterile PBS.
5. Block the plate with 100 l per well with culture medium (RPMI) for at least 2 hours at 37°C. 7. Count the cells (e.g. using a cell counter) and resuspend at the desired cell density (e.g. 1x10 6 cells/ml for SMCs, 8x10 6 cells/ml for bone marrow) in pre-warmed culture medium (RPMI).
8. Generate 1:2 dilution series for each sample in a separate 96-well culture plate, starting with 250,000 cells for SMCs, and 2x10 6 cells for bone marrow cells.
9. Decant the blocking medium of the filtration plate and add 100 l of each sample dilution, resulting in a starting cell number of 100,000 for SMCs and 800,000 cells for bone marrow samples.
10. Incubate the samples over night at 37°C and 5% CO2. During this time, do not open the incubator door, as it may result in smeared spots difficult to read.
Spot development (Day 3)
The following steps can now be performed on the benchtop.
11. Discard the cell solution and wash the plate 6x with wash buffer. Incubate for 1 hour at RT.
13. Discard the detection antibody and wash the plate 3x with wash buffer, followed by 3 washes with PBS-only to avoid interference of Tween with spot development.
14. Take (Fig. 2) . Staining is for 10 min on ice, followed by washing with PBS/0.5% BSA and resuspending the cells in appr. 2 ml PBS/0.5% BSA (inquire the appropriate cell density of the fraction to be sorted from the cell sorter operator). needle using a 1 ml syringe to shear the DNA. 5. Remove ethanol (the remaining drop can be removed using a G26½ needle placed on a pipette) and dry the pellet on the bench for 15 min, until ethanol has evaporated. Dissolve RNA in 7 l DEPC-treated water. RNA can be stored at -80ºC if not continuing with the cDNA synthesis.
6. Make 2 mM dilutions of the C 1-cDNA (and if applicable the C -cDNA) primers (Table 1) 2. Isolate PCR product using a suitable gel extraction method such as the QIAquick
Gel Extraction kit (Quiagen) or an equivalent kit using the manufacturer's instructions. Elute PCR product with 30 l H2O. Measure the DNA concentration e.g. using Nanodrop methodology or agarose gel-based quantification methods.
Optional: 20 ng of DNA can be loaded onto an agarose gel to verify that all bands appear at the same intensity. sequencing together with an appropriate primer (e.g. T7 primer) using the sequencing company's guidelines; e.g. some companies require 4 ng/l for direct sequencing of PCR products; usually, the company will purify the PCR product in house before sequencing, so that removal of excess PCR primers is not required. 
Notes
(1) For the study of T-independent type-I and type-II responses, mice are immunized i.p. with 20 µg NP-LPS or 30 µg of NP-AECM-FICOLL, respectively, dissolved in sterile PBS respectively. Serum is isolated from blood as described in section 3.2.1 7 days following immunization. ELISA is performed as described in section 3.2.2, except that the anti-NP serum response of IgM and IgG3 antibodies is measured.
(2) The adjuvant alum is an alternative for Freund's adjuvant and can be used interchangeably in the study of the T-dependent response to NP. Before deciding on an adjuvant, it is recommended to inquire with the institution's IACUC which adjuvant is acceptable.
(3) The analysis for somatic hypermutation in V186.2 rearrangements following NPimmunization is commonly performed around days 12 to 14 after immunization, which is considered to be at the height of the GC reaction.
(4) Different antibody combinations can be used to identify GC B cells, including the commonly used anti-CD95/anti-CD38 combination to identify CD95 hi CD38 lo GC B cells (13) , and anti-CD19 is a suitable alternative for anti-B220. GL7, which is highly expressed on GC B cells, can be used as an alternative for CD95, e.g. in the combination anti-GL7/anti-CD38. A suitable fluorochrome combination is B220-FITC, IgM-APC and IgD-PE. cDNA libraries generated with the C cDNA primer as described in section 3.5.7 are amplified with the V186.2-leader and C-PCR primer in the 1 st round and the V186.2-nested and C-PCR primer in the second round (for PCR primers, see Table 1 ). amplified for 30 cycles with the amplification conditions described in section 3.5.2.1 using the V186.2-leader primer (Table 1 ) and a reverse primer hybridizing in the C1-membrane-encoding exon (mC1-PCR oligo: 5'-CAGCACAGGTCTCGTCCAGTTG-3'). Generally, no nested PCR strategy is required, but can be implemented using the mC1-PCR and the V186.2-nested primer Table 1 ).
(9) A strategy has been published that allows the amplification of V186.2 rearrangements from genomic DNA isolated from B-cell subsets (14) . In our own experience, this strategy leads to the amplification of a large percentage of non-V186.2 gene segments (~40%), and unless there is a particular requirement to amplify V186.2 rearrangements from genomic DNA, in our opinion the cDNA-based approach is more cost effective. 
